|
|
Article: United States: ResMed launches sleep apnea study in heart failure patients.
- Article from:
- TendersInfo
- Article date:
- October 8, 2008
CopyrightCOPYRIGHT 2008 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: manish03
ResMed, a developer and manufacturer of medical equipment for treating respiratory disorders, has launched the Serve-HF study to investigate the use of its AutoSet CS2 device in the treatment of sleep-disordered breathing that affects patients with chronic heart failure. The international Serve-HF study will focus specifically on the impact of treatment of central sleep apnea (CSA) in patients with heart failure. According to the company, up to 76% of patients with heart failure also suffer from sleep-disordered breathing, in which normal breathing during sleep is interrupted. Around two-thirds of those patients with clinically significant ...